INTRODUCTION
Antimicrobial stewardship is a method of overseeing antimicrobial use in healthcare facilities to ensure that every patient requiring antimicrobial therapy receives optimal therapy [1] . There is a growing body of evidence that antimicrobial stewardship programs decrease unnecessary exposure to antimicrobials and subsequently reduce Clostridium difficile infections [2,3 & ,4
& , [5] [6] [7] [8] , slow the emergence of antimicrobial resistance [9] [10] [11] , and result in significant cost savings for institutions [12] [13] [14] [15] [16] [17] [18] [19] . Although it has taken some time, there is increasing recognition of the benefits of antimicrobial stewardship in the healthcare environment. However, the term still does not have the name recognition it deserves to pique the interest of regulators and hospital administrators. Additionally, it is not a term commonly used or easily understood by the general public. It is possible that a name change to 'antimicrobial safety' can accelerate acceptance of the importance of antimicrobial stewardship and make the concept more palatable to patients, colleagues and administrators. By highlighting the many antimicrobial stewardship outcomes related to preventing harm at both the individual and the societal level, it is possible to elevate stewardship to the senior levels of hospital administration and also to open the dialog with patients and families about the importance of appropriate antibiotic use. This review highlights some specific goals antimicrobial stewardship programs can focus on to make the case that antimicrobial stewardship is synonymous with antimicrobial safety.
In 2003, New England Journal of Medicine published a manuscript entitled, 'Infection Control -A Problem for Patient Safety' [20] . The article made the case as to why hospital administrators and regulatory bodies should be interested in infection control and highlighted the link between the poor infection control practices and the safety of hospitalized patients. It emphasized that between 5 and 10% of patients admitted to acute care hospitals develop at least one hospital-acquired infection and that these numbers have been increasing over time. As a requirement for participation in The Centers for Medicare and Medicaid Services (CMS) in the United States, an acute healthcare facility must have 'an active program for the prevention, control, and investigation of infections and communicable diseases. A person or many persons must be designated as an infection control officer or officers to develop and implement policies governing control of infections and communicable diseases (website: http:// www.gpo.gov/fdsys/pkg/CFR-2011-title42-vol5/ pdf/CFR-2011-title42-vol5-part482.pdf. Accessed 28 February 2014). As a result, infection control programs are found in every acute healthcare facility in the United States.
The most recent data suggest that up to 55% of all hospitalized patients receive an antibiotic [21] and that between 30 and 50% of that use may be inappropriate leading to preventable complications, including adverse drug events and some of the same hospital-acquired infections that prompted the infection prevention mandates of more than two decades ago [22, 23] . Antimicrobial stewardship and infection control are partners in patient safety and should receive similar institutional attention and support. However, although a decade since The New England Journal publication and despite data that antimicrobial misuse is more common than hospital-acquired infections [22, 24] , antimicrobial stewardship has failed to garner the national attention and incentives necessary to render these programs' requirements for acute healthcare facilities [25, 26 && ]. Acute care facilities are faced with competing priorities as to where they need to place their resources, largely dictated by incentives and mandates, underscoring the importance of regulatory action requiring stewardship programs.
WHAT EXACTLY IS PATIENT SAFETY?
It is a very easy task to convince people why we need mechanisms in place to ensure patient safety. However, the same has not been true historically for antimicrobial stewardship [27] . As defined by Wikipedia, 'Patient safety is a new healthcare discipline that emphasizes reporting, analysis, and prevention of medical error that often leads to adverse healthcare events' (website: http://en.wikipedia. org/wiki/Patient_safety. Accessed on 1 February 2014). According to the Agency for Healthcare Research and Quality, 'Patient safety . . . applies safety science methods towards the goal of achieving a trustworthy system of healthcare delivery . . .
[and] minimizes the incidence and impact of, and maximizes the recovery from, adverse events [28] . ' As we think about these definitions, are they really very different from antimicrobial stewardship? Arguably every stewardship program emphasizes reducing the unintended consequences of antimicrobials in its program goals [29 && ]. Unfortunately, we have no comprehensive national database of adverse drug reactions as a consequence of both necessary and unnecessary antimicrobial uses in the United States.
Shehab et al. [30] set out to evaluate the national scope of antibiotic related adverse events, including analysis of data from the National Electronic Injury Surveillance System. An estimated 142 505 annual visits were made to United States emergency departments as a consequence of antibiotic-related adverse events. In fact, antibiotics were implicated in approximately 20% of all emergency department visits for drug-related adverse events. Again, with much antibiotic use deemed unnecessary [21, 23] ,
KEY POINTS
Antimicrobial stewardship is a method of overseeing antimicrobial use in healthcare facilities to ensure that every patient requiring antimicrobial therapy receives optimal therapy.
Patient safety is an integral component of antimicrobial stewardship.
Highlighting some of the stewardship activities related to preventing patient harm can be key to pique the interests of regulators, hospital administrators, colleagues and the general public about the importance of stewardship activities.
Some of the activities an antimicrobial stewardship team may already be engaging in or could engage in which emphasize the link between safety and stewardship include the following: reducing Clostridium difficile infections, establishing an outpatient parenteral antibiotic therapy program, overseeing therapeutic drug monitoring, routinely updating perioperative prophylaxis guidelines, developing protocols to address antibiotic allergies, and overseeing medication reconciliation and drug-drug interaction monitoring.
many of these encounters might have been preventable. By minimizing unnecessary antibiotic use by even a marginal amount, a significant impact could be made on reducing adverse drug reactions and their unnecessary harm and costs.
DEMONSTRATING THE LINK BETWEEN STEWARDSHIP AND SAFETY
To convince regulators, hospital administration, clinical colleagues and the public that there is indeed a very real connection between antimicrobial stewardship and patient safety, it is important to highlight concrete systematic examples establishing the link. Although the goals of antimicrobial stewardship are much larger than cost-saving strategies, attaching a dollar sign to the proposed goals or focusing on an area in which there have been recent or significant litigious concerns can be very appealing to administrators. Adverse events related to antimicrobials are pervasive in the medical literature. Although antibiotic use leads to the emergence of resistance [9, 10] , which can be increasingly difficult and costly to treat, this is likely not a very effective selling point for stewardship as it remains difficult to demonstrate a causal relationship.
In the following, we highlight a few examples of outcomes focusing on avoiding harm related to antimicrobial stewardship.
CLOSTRIDIUM DIFFICILE INFECTIONS
Perhaps one of the most obvious associations between antimicrobial stewardship and patient safety is a reduction in Clostridium difficile infections (CDIs). CDI prevention in the hospital setting has been a Joint Commission patient-safety goal for some time and is at the forefront of many hospital initiatives. In the antimicrobial stewardship literature, there is already evidence that stewardship is paramount to achieving this goal [2,3
To highlight a few of these, Valiquette et al.
[2] reported management in response to a toxigenic strain of CDI in Quebec. Infection control efforts were escalated in response to the outbreak but only had a minimal impact. It was not until dissemination of antibiotic guidelines developed by a stewardship team aimed at decreasing the use of antibiotics most commonly associated with CDI (reinforced by prospective audit and feedback) that a marked reduction in CDI was observed.
Malani et al.
[3 & ] evaluated the impact of a priorapproval program targeting select antibiotics and performed a before-and-after study over a 2-year period to evaluate antibiotic use and CDI. Their program was associated with a 25% decrease in targeted antibiotics and a 50% reduced odds of developing CDI, in the absence of other interventions aimed at reducing CDI rates. This study is particularly impressive because some of the most notorious agents associated with subsequent CDI, such as cephalosporins, clindamycin, and fluoroquinolones, were not included in the prior-approval program. Similarly, a 6-year study evaluating the impact of an intervention restricting the use of antibiotics deemed particularly high-risk for subsequent CDI through prior-approval and postprescription review with feedback was associated with significant reductions both in high-risk antibiotics and in CDI rates [6] .
In the 2010 Society for Healthcare Epidemiology of America (SHEA) and Infectious Diseases Society of America (IDSA) guidelines, antimicrobial stewardship is an A-II recommendation [31] . The American College of Gastroenterology Guidelines from 2013 state, 'Antimicrobial stewardship is recommended to reduce the risk of CDI [32 & ].' CDI must be included as an important safety measure of any antimicrobial stewardship intervention that is undertaken. It should be clear to administrators that controlling CDI rates requires a joint partnership between infection control and antimicrobial stewardship.
Monitoring outpatient antimicrobial therapy
Peripherally inserted central catheters (PICCs) are often placed when a patient is in an acute care setting to aid with parenteral antibiotic administration (along with other fluids and medications) that may continue as an outpatient. Data from the 1990s indicate that greater than 1 in every 1000 Americans use outpatient parenteral antibiotic therapy (OPAT) services annually [33] with an estimated growth rate of 15-20% per year [34] .
Unlike what is observed in the inpatient setting, OPAT is often decentralized, making appropriate oversight by healthcare providers challenging. In our experience, patients sometimes have retention of PICCs even after parenteral therapy is discontinued, simply because there is not a system in place to ensure appropriate patient follow-up. In patients with PICCs, as an intravenous form of access is already available, determining whether antimicrobials can be changed to the enteral route (assuming antibiotics are still actually needed) is often overlooked. In the past, encouraging a change from the intravenous to the enteral route was large driven by cost savings. Now that many intravenous antibiotics are available as generic medications, it is difficult to demonstrate significant cost savings from drug charges associated with conversion from intravenous to oral medications. Instead, the emphasis should be placed on the avoidance of complications from unnecessary PICCs.
Chary et al. [35] surveyed 454 infectious diseases clinicians about their experience with OPAT and PICC complications. Ninety-four percent of respondents indicated that their patients were frequently discharged to continue OPAT outside the hospital setting, with significant variability in monitoring for adverse events. Of all respondents, 68% mentioned that they collectively encountered 1951 infectious (e.g., catheter-associated bloodstream infections, exit-site infections, or tunnel infections) and noninfectious complications (e.g., thrombosis and line breakage) related to OPAT in the previous 12 months. Most of the survey respondents indicated that there was no system in place to ensure all patients receiving OPAT had appropriate follow-up. Thirteen members reported that 14 of their patients had died during the previous year while receiving OPAT and 16 physicians reported having been involved in lawsuits as a result of OPAT complications. A pediatric study evaluating 2574 PICCs placed in children found that approximately 21% were removed prematurely because of PICC-associated complications, and this was focusing mainly on the inpatient setting in which there is likely more supervision with PICC care [36] . Of those removed for infectious complications, almost 60% met the National Healthcare Safety Network's criteria for a central line-associated bloodstream infection [37] . Reducing central line-associated bloodstream infections is a patient-safety goal of every acute-care hospital in the United States and one in which antimicrobial stewardship can play an important role.
Investigators at the Cleveland Clinic evaluated the role of mandatory infectious disease consultation for intravenous antimicrobials at hospital discharge. Such a policy resulted in avoidance of OPAT in 28% of patients [38] . No untoward effects were noted; there were no emergency department visits or rehospitalizations within 30 days of hospital discharge for these patients. Similarly, of 44 patients scheduled to continue OPAT who received mandatory infectious diseases consultations at the time of hospital discharge, 89% had some change in antibiotic therapy, including the discontinuation of antibiotic therapy [39 & ].
Mandatory OPAT consultations and follow-up as outpatients could be the tasks of an antimicrobial stewardship team. Although it would be extremely difficult for a stewardship program to monitor all antimicrobials prescribed upon hospital discharge, focusing on parenteral ones can have a meaningful impact on patient safety. The stewardship team can take the lead in developing a centralized service to monitor patients receiving OPAT to ensure patients receiving antibiotics via PICCs actually require continued intravenous management as outpatients, to determine if alternative less toxic agents can be used, to follow up appropriate therapeutic drug monitoring (TDM), to oversee clinical and laboratory evaluation for adverse drug and catheter-related events, and to determine when therapy can be discontinued [38, 40] . Establishing a system for monitoring OPAT could be an important step to avoiding harm in patients unnecessarily receiving PICCs at discharge and that is patient safety.
Therapeutic drug monitoring
As our knowledge of the association between serum drug concentrations and both clinical outcomes and adverse drug events has improved, so has the attention to appropriate TDM. A classic example relates to vancomycin.
In the 1980s, the recommendations were to target vancomycin troughs between 5 and 10 mg/ml. Since then, there have been many advances in our understanding of vancomycin pharmacokinetics and pharmacodynamics [41] [42] [43] [44] . In 2009, the consensus guidelines from the American Society of Health-System Pharmacists, the Society of Infectious Diseases Pharmacists, and IDSA on vancomycin dosing and therapeutic drug monitoring in adults recommended targeting troughs of 15-20 mg/ml for serious methicillin-resistant Staphylococcus aureus (MRSA) infections as the pharmacokinetic-pharmacodynamic measures associated with these troughs have been associated with improved clinical outcomes [45] [46] [47] . With the 2009 guidelines advocating for higher vancomycin troughs, we also witnessed a rise in acute renal injury from vancomycin use, particularly when appropriate systems for TDM of vancomycin troughs are not in place [48] [49] [50] [51] .
TDM represents an important crossroad of stewardship and safety. TDM programs have been associated with significant improvement in clinical and economic outcomes for patients receiving antibiotics in which monitoring drug levels is necessary. Factoring in the costs of extended hospital stays while awaiting improvement of renal function and even dialysis in some cases, establishing TDM programs also represents an important target for cost-savings.
In a study of 961 United States hospitals, hospitals without pharmacist oversight of vancomycin and aminoglycoside TDM had higher overall patient mortality, hospital length of stay, and total Medicare charges than those with a TDM system in place [52] . In addition, hearing loss and renal impairment were approximately 35% and 10% higher in patients without pharmacist involvement [52] .
Systematic TDM can also be extended to agents in which serum concentrations are not easily measurable but in which suitable proxies exist, for example, oxacillin-induced liver injury. In fact, antimicrobial agents are the leading cause of druginduced liver injury, accounting for approximately half of all cases [53] . These insults are often longlasting. In a study of 300 patients with druginduced liver injury, 14% of the patients continued to have evidence of hepatotoxicity 6 months after the initial injury and about 4% of the patients died as a consequence of the hepatic injury. As TDM is an essential component of any stewardship program, it should be made clear to administrators that TDM falls under the operations of patient safety.
Perioperative prophylaxis guidelines
Despite no national incentives for formal stewardship programs, CMS does have several metrics related to antibiotic use. Of the measures that have been incorporated into value-based purchasing (which is now being used to calculate reimbursement for hospitals), several measures are related to surgical prophylaxis: appropriate selection of surgical prophylaxis, appropriate timing of surgical prophylaxis administration, and discontinuation of surgical prophylaxis at 24 h. With reimbursement at stake, the risk of increased surgical site infections captures the attention of administrators.
There are approximately 30 million surgeries in the United States per year and this number is growing [54] [55] [56] . Surgical site infections account for 16% of all hospital infections in the United States [57, 58] and result in a three-fold increased risk of death [59] . There is a large body of evidence demonstrating reductions in surgical site infections when appropriate perioperative prophylaxis is used [60] [61] [62] [63] [64] [65] [66] . However, existing evidence suggests that there is still room for improvement in the use of antibiotics related to perioperative prophylaxis [23, [67] [68] [69] . It has been shown that pharmacist-directed management of surgical prophylaxis has been associated with improved survival, decreased lengths of stay, and decreased hospital charges compared with patients undergoing surgeries in hospitals without pharmacist involvement in perioperative prophylaxis [21] . There are unique aspects of drug-dosing that a stewardship team can bring to the table, including dosing for patients with obesity, dosing for patients with compromised renal function, antibiotic selection for patients with allergies, antibiotic selection for patients colonized with MRSA, amongst others. Improving and regularly updating local perioperative prophylaxis guidelines with input from surgeons and anesthesiologists should be emphasized as a patient-safety priority of the antimicrobial stewardship team.
Antibiotic allergies
The stewardship team can have a pivotal role in ensuring that systems are in place to identify all patients at risk for antibiotic allergies. By preventing patients from receiving medications they are truly allergic to, subsequent emergency department visits related to drug allergies can be avoided. Both readmissions and emergency department visits soon after discharge are important to administrators and are important patient-safety goals.
In the case of factitious drug allergies, a review of patients with reported antibiotic allergies can ensure that patients receive the optimal agent(s) for their infections. Patients may have allergies documented in their chart without further exploration into the nature of the allergies, and whether the documented allergies should preclude receipt of the agent(s) considered first-line treatment for the given infection. Often these patients receive suboptimal alternative agents, increasing their risk of treatment failure. The alternative agent selected may also be more toxic. Penicillin allergies represent the most common reported allergies [69] . In an effort to avoid penicillins in patients labeled as 'penicillin allergic' patients commonly receive broader and sometimes less adequate antimicrobial therapy than those patients without penicillin allergies [70] .
It has previously been shown that when a stewardship team oversees the systematic review of medical records of patients with antibiotic allergies, there can be significant reductions in orders for antibiotics to which patients have allergies, as well as decreases in actual adverse drug events attributable to antibiotics [71] . Stewardship teams can promote patient safety by performing mini-consults on patients labeled as allergic to an antiinfective to determine: first, if the allergy is indeed a true allergy, second, if the patient would benefit from allergy testing, and third, suitable alternative agents in the case of true allergies.
Medication reconciliation and drug-drug interactions
Patients are particularly vulnerable to medication errors when they are transferred from one unit to another or to another acute care facility, rehabilitation center, nursing home, or to their home. Common mistakes include incorrect drugs, incorrect dosages, inadequate TDM, and failure to recognize drug-drug interactions. Additionally, delays in first doses of medications or missed doses can occur. Sometimes the mistakes are relatively easy to correct. For example, prescribers may recount antibiotic therapy upon the first day of discharge, even though the patient may have been receiving the same or a similarly active antibiotic for several days during the inpatient admission. Medication reconciliation both for patients admitted already receiving antibiotic therapy and for patients being discharged with the need to continue antibiotics is crucial to ensure patient safety. Pharmacist-led medication reconciliation has been shown to reduce discrepancy-related adverse drug events [72] . In fact, antibiotics were the most common class of agents subject to discrepancy-related adverse drug events. Not surprising, hospitals without pharmacists involved in the admission or transfer process or both had about 35% more adverse drug reactions than those without such a system in place [73 & ]. These hospitals also had an excess of 443 deaths, 85 554 hospital days, and $11 745 342 in total Medicare charges.
The antimicrobial stewardship team can oversee staff pharmacists who review discharge antibiotics to evaluate for drug-drug interactions and other important potential adverse drug reactions. As stewardship teams are involved with selecting antimicrobials available on hospital formularies, they can emphasize their importance in selecting the safest possible agents when multiple agents have similar spectra of activity. Additionally, as many hospitals are moving toward electronic medical records, and as existing electronic medical records are becoming increasingly complex, the stewardship team can be pivotal in ensuring that antibiotic selection and dosing is in accord with the formulary and that appropriate alerts to check for drug-drug interactions, notable toxicities, and TDM are in place.
CONCLUSION
Although implementation of antimicrobial stewardship programs across healthcare facilities is neither an incentivized nor a national mandate in the United States, there are ongoing discussions about moving in this direction. In the meantime, it is important that both existing stewardship programs and those seeking to establish stewardship programs emphasize that stewardship is an integral component of patient safety. Stewardship metrics must include important measures of safety, preferably already established ones tied into reimbursement to get the attention of administrators. 'Harm reports' come out regularly at many institutions and by selecting the proper safety measures that can be impacted by stewardship programs, harm reports related to antibiotics can become standard of care across healthcare facilities.
Unger NR, Gauthier TP, Cheung LW. Penicillin skin testing: potential implications for antimicrobial stewardship. Pharmacotherapy 2013; 33:856-867. This review discusses the role that antimicrobial stewardship plays in improving the recognition of genuine and factitious allergies. It discusses the harm associated with the liberal diagnosis of allergies both for specific patients and for society as a whole.
